Cellular Dynamics Q1 Revenues Improve 21 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Cellular Dynamics reported after the close of the market on Monday that revenues in its first quarter were up 21 percent year over year, driven by collaborations and partnerships.

The company said that for the three months ended March 31, it had $2.9 million in revenues, compared to $2.4 million in the first quarter of 2013. Product sales were down 17 percent to $1.5 million from $1.8 million, but collaborations, partnerships, and other revenues more than doubled to $1.5 million from $636,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions.

Ancestry.com is eyeing an expansion into genomic risk assessments, the Verge reports.